OMICSOFT
QIAGEN OmicSoft and Biomedical Knowledge Base
Novel discoveries utilizing public data through QIAGEN Omicsoft Lands - March...
In this 90-minute video, users will learn how to discover and validate biomarkers, key...
QIAGEN OmicSoft and Biomedical Knowledge Base
Supporting Biomarker Discovery One Cell at a Time - Introduction to QIAGEN...
Single-cell gene expression analysis helps biologists and bioinformaticians reveal...
QIAGEN IPA
Discovery from public oncological data using QIAGEN Omicsoft OncoLand and...
In this 90-minute training, we will discuss how to discover and validate biomarkers as...
QIAGEN OmicSoft and Biomedical Knowledge Base
Expression data analysis using QIAGEN Omicsoft Studio - Sep 28 2021
In this training, users will learn how to generate downstream outputs such as...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN...
In this 90-minute training, users will learn how to do drug treatment, toxicology and...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug Target and Biomarker Investigation using OmicSoft OncoLand
In this 90-minute training, attendees will learn how to use basic expression analysis...
QIAGEN OmicSoft and Biomedical Knowledge Base
Authenticated and reproducible cell line 'omics data
Have you ever tried to access the genomic profiles of cell lines before using them in...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN IPA and...
In this 90-minute training, you’ll learn how to do drug treatment, toxicology and...
QIAGEN OmicSoft and Biomedical Knowledge Base
Biomarkers and drug target investigation using manually curated, unified...
There is an almost incomprehensible amount of diverse, non-standardized ‘omics data...
QIAGEN IPA
Summer 2025 IPA Interpret and OmicSoft Explorer Enhancements
Join us to review exciting new features in IPA Interpret and OmicSoft Explorer. We will...
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitor and immuno-oncology investigation leveraging curated...
While there is great interest in the scientific community to investigate drug targets...